Anca Bulgaru is an Oncology physician affiliated with Yale Cancer Center. OpenAlex indexes 18 publications with 239 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Washington St
Ste 220 Eastern Ct Hematology & Oncology
Norwich, CT 06360
Telephone
860-886-8362Registry record last updated 22 Jul 2013.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20231 payment
- Janssen Biotech, Inc.Program year20211 payment
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
50.9%Aromatase Inhibitor34.1%Anastrozole80%Exemestane10%Letrozole9%Part D<11 patientsEstrogen Agonist/Antagonist9.2%Tamoxifen Citrate100%Part D≥42 patients+ 3 more classes in this area
Nervous system
19.2%Gabapentinoids6.5%Gabapentin100%Part D≥32 patientsOpioid Agonist4.9%Oxycodone-Acetaminophen37%Oxycodone Hcl35%Fentanyl28%Part D<11 patients+ 4 more classes in this area
Blood & clotting
14.6%Factor Xa inhibitor12.8%Eliquis68%Xarelto32%Part D≥33 patientsLow Molecular Weight Heparin0.9%Enoxaparin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Decreasing the Interval Wait Times for Screening Mammogram Results Using the “Reflex Testing” Algorithm
Journal of Breast Imaging
2022 - Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis
Journal of Vascular Surgery Venous and Lymphatic Disorders
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Ian Krop, MD
Yale Cancer Center
Maryam Lustberg, MD
Yale Cancer Center
Pamela Kunz, MD
Yale Cancer Center
Anne Chiang, MD
Yale Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”